I qualified as a medical doctor in 2009 from Imperial College, London with an intercalated BSc in Medical Sciences with Haematology. My undergraduate research focused on deciphering the function of N-linked glycosylation sites on the synthesis and function of von Willebrand Factor, a blood glycoprotein with an essential role in haemostasis. In 2011, I commenced an Academic Clinical Fellowship in Gastroenterology, and quickly developed and interest in immune-mediated liver diseases, specifically primary sclerosing cholangitis (PSC). Alongside my clinical training in Gastroenterology and Hepatology, I spent several years working with the UK-PSC Consortium (http://www.uk-psc.com/) to develop a risk scoring system for adverse patient outcomes, using clinical phenotype data from 1000 patient recruited to the UK-PSC Genetics Study. The collaboration between UK-PSC and the Anderson group led to my joining the Anderson team in 2016 as a Wellcome Trust Clinical PhD Fellow. Here, my work focuses on furthering our understanding of genetic risk variants through RNA sequencing of PSC-relevant tissues. My extra-medical interests include running around after my young daughter, playing the violin and contesting parking penalty notices.